Mylan Faces $100M Tax Bill Over Drug Agreement With Forest
By Brian Mahoney ( July 18, 2014, 3:08 PM EDT) -- Mylan Inc. is protesting an Internal Revenue Service determination finding it owes the U.S. government $100 million in taxes arising from a drug development agreement with Forest Laboratories Holdings Ltd., in a complaint made public just days after the generics maker cut a $5.3 billion deal to shift its tax obligation overseas....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.